Plain-English translation of NCT07071935 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether people with ALS benefit from starting non-invasive ventilation (a breathing support mask) earlier than doctors typically recommend. Non-invasive ventilation is a mask-based therapy that helps your lungs work when ALS weakens your breathing muscles. The study wants to learn whether starting this treatment sooner improves both how long you live and your quality of life.
ALS gradually weakens the muscles you use to breathe, and breathing problems are the main reason people with ALS become seriously ill. While non-invasive ventilation is known to help, doctors aren't sure when to start it—some wait until breathing is very severely affected, while others start earlier. This study will help answer that question and find the best timing for this treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either start non-invasive ventilation right away or receive your usual ALS care. The study team will teach you how to use the breathing mask, help you find the right fit and settings, and monitor your breathing levels and quality of life over time. You'll attend study visits to check how you're doing and whether the treatment is helping.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States
18 Years and older
Last updated on clinicaltrials.gov in June 2026.